In collaboration with Ferring Pharmaceuticals, SCIDaR conducted research in Kano State to identify gaps in managing these conditions.
The study revealed that 98% of primary healthcare providers have not received training in managing these conditions in over five years, leading to underutilisation of essential medicines like magnesium sulfate. The findings are a wake-up call, underscoring the urgent need for revitalised training programs, heightened community awareness, and bold, innovative strategies to safeguard the lives of mothers and their babies across Nigeria.
Read moreSCIDaR offers dynamic and rewarding opportunities to individuals who desire to gain experience and develop key professional skills while also working to contribute to SCIDaR’s organizational goals within six (6) months.